Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.

M. Leukemia inhibitory factor (LIF). oncostatin M (OsM) and interleukin-6 (IL-6) are members of a cytokine family, which are produced by activated macrophages and glomerular mesangial cells. These cytokines have been implicated in the pathogenesis of glomerular inflammation, but their action on glomerular cells is presently unclear. Therefore, we examined the effects of IL-6, OsM and LIF on chemokine synthesis of rat mesangial cells in culture. While LIF as well as IL-6 up-regulated monocyte chemotactic protein-1 (MCP-1) mRNA expression, OsM showed no such effect. The induction of MCP-1 mRNA by LIF and IL-6 was transient, peaking at one to two hours and two to three hours, respectively, and returning to background levels within several hours. Induction of MCP-1 mRNA by LIF and IL-6 was strongly inhibited by dexamethasone. LIF activated STAT factors in mesangial cells, suggesting their involvement in signal transduction pathways that lead to LIF-stimulated up-regulation of MCP-1 mRNA. By contrast, LIF. IL-6 and OsM failed to affect the expression of the chemokines, macrophage inflammatory protein-2 (MIP-2) and RANTES. The rapid, transient and differential regulation of MCP-1 expression induced by LIF and IL-6 contrasted with uniformly powerful effects of the proinflammatory cytokines IL-1 beta and TNF alpha that induced all tested chemokines for prolonged time periods. These results suggest that the selective and transient induction of MCP-1 by LIF and IL-6 may play a role in the preferential attraction of monocytes to the injured glomerulus.

[1]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[2]  E. Papakonstantinou,et al.  A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Feng,et al.  Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[4]  A. Takeshita,et al.  Retinoic acid suppression of c-fos gene inhibits expression of tumor necrosis factor-alpha-induced monocyte chemoattractant JE/MCP-1 in clonal osteoblastic MC3T3-E1 cells. , 1994, The Journal of biological chemistry.

[5]  A. Sica,et al.  Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. , 1990, Journal of immunology.

[6]  P. Huie,et al.  RANTES chemokine expression in cell-mediated transplant rejection of the kidney , 1994, The Lancet.

[7]  S. McColl,et al.  Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. , 1993, The Journal of biological chemistry.

[8]  B. Rovin,et al.  Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[9]  A. Muraguchi,et al.  Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.

[10]  R. Takigiku,et al.  Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. , 1993, American journal of respiratory cell and molecular biology.

[11]  G. Fey,et al.  The LIF response element of the alpha 2 macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells. , 1995, Cytokine.

[12]  Y. Xia,et al.  Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. , 1995, The Journal of clinical investigation.

[13]  J. Heath,et al.  Are LIF and related cytokines functionally equivalent? , 1994, Experimental cell research.

[14]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Rollins,et al.  In vivo and in vitro inhibition of JE gene expression by glucocorticoids. , 1991, The Journal of biological chemistry.

[16]  E. Schulze-Lohoff,et al.  Extracellular ATP stimulates proliferation of cultured mesangial cells via P2-purinergic receptors. , 1992, The American journal of physiology.

[17]  S. Dower,et al.  Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. , 1994, The Journal of biological chemistry.

[18]  R. Terkeltaub,et al.  Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. , 1992, The Journal of clinical investigation.

[19]  T. Rose,et al.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Goppelt‐Struebe,et al.  Synergistic induction of monocyte chemoattractant protein‐1 (MCP‐1) by platelet‐derived growth factor and interleukin‐1 , 1995, FEBS letters.

[21]  A. Hartner,et al.  Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. , 1994, Kidney international.

[22]  G. Van,et al.  Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis. , 1996, Kidney international.

[23]  D. Schlöndorff,et al.  The role of chemokines in the initiation and progression of renal disease. , 1995, Kidney international. Supplement.

[24]  F. Thaiss,et al.  Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. , 1993, Kidney international.